For: | Li HL, Ji WB, Zhao R, Duan WD, Chen YW, Wang XQ, Yu Q, Luo Y, Dong JH. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: Retrospective analysis. World J Gastroenterol 2015; 21(12): 3599-3606 [PMID: 25834326 DOI: 10.3748/wjg.v21.i12.3599] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i12/3599.htm |
Number | Citing Articles |
1 |
Tengfei Si, Yongjun Chen, Di Ma, Xiaoyong Gong, Kui Yang, Ruoyu Guan, Chenghong Peng. Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trials. Scandinavian Journal of Gastroenterology 2016; 51(12): 1512 doi: 10.1080/00365521.2016.1216588
|
2 |
Laura Kulik, Julie K. Heimbach, Feras Zaiem, Jehad Almasri, Larry J Prokop, Zhen Wang, M. Hassan Murad, Khaled Mohammed. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta‐analysis. Hepatology 2018; 67(1): 381 doi: 10.1002/hep.29485
|
3 |
Francisco Villalba-López, Luis Francisco Sáenz-Mateos, Maria Isabel Sánchez-Lorencio, Virginia De La Orden-García, Felipe Alconchel-Gago, Pedro Antonio Cascales-Campos, Carmen García-Bernardo, José Antonio Noguera-Velasco, Alberto Baroja-Mazo, Pablo Ramírez-Romero. Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32879-9
|
4 |
Konstantinos Ouranos, Anthi Chatziioannou, Ioannis Goulis, Emmanouil Sinakos. Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation. World Journal of Transplantation 2022; 12(11): 331-346 doi: 10.5500/wjt.v12.i11.331
|
5 |
René Fahrner, Felix Dondorf, Michael Ardelt, Yves Dittmar, Utz Settmacher, Falk Rauchfuß. Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival. World Journal of Gastroenterology 2015; 21(42): 12071-12082 doi: 10.3748/wjg.v21.i42.12071
|
6 |
Li Shen, Guangshun Zhang, Zhaohuan Lou, Guanhua Xu, Guangji Zhang. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo. BMC Complementary and Alternative Medicine 2017; 17(1) doi: 10.1186/s12906-016-1548-4
|
7 |
Cheng-Shi Chen, Fang-Kun Li, Chen-Yang Guo, Jin-Cheng Xiao, Hong-Tao Hu, Hong-Tao Cheng, Lin Zheng, Deng-Wei Zong, Jun-Li Ma, Li Jiang, Hai-Liang Li. Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Oncotarget 2016; 7(6): 7241 doi: 10.18632/oncotarget.6892
|
8 |
Gustavo Pilotto Domingues Sá, Jorge Roberto Marcante Carlotto, Fernando Pompeu Piza Vicentine, Luiz Romero, Dario Fernandes Perdomo Tejada, Alcides Augusto Salzedas Netto, Gaspar de Jesus Lopes Filho, Adriano Miziara Gonzalez. Avaliação do tratamento dos nódulos do hepatocarcinoma nos pacientes em lista de espera para transplante hepático. Revista do Colégio Brasileiro de Cirurgiões 2017; 44(4): 360 doi: 10.1590/0100-69912017004010
|
9 |
Daniel A. Butcher, Kelli J. Brandis, Haolu Wang, Liam Spannenburg, Kim R. Bridle, Darrell HG. Crawford, Xiaowen Liang. Long-term survival and postoperative complications of pre-liver transplantation transarterial chemoembolisation in hepatocellular carcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology 2022; 48(3): 621 doi: 10.1016/j.ejso.2021.09.017
|
10 |
Christiana J. Crook, Daneng Li. Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma. Current Oncology Reports 2023; 25(10): 1191 doi: 10.1007/s11912-023-01455-9
|
11 |
Peng Li, Huiguo Ding. Stratified screening of hepatocellular carcinoma in high-risk populations. Radiology of Infectious Diseases 2015; 2(2): 109 doi: 10.1016/j.jrid.2015.07.002
|
12 |
Tengfei Si, Yongjun Chen, Di Ma, Xiaoyong Gong, Ruoyu Guan, Boyong Shen, Chenghong Peng. Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: A meta‐analysis. Journal of Gastroenterology and Hepatology 2017; 32(7): 1286 doi: 10.1111/jgh.13727
|
13 |
Lei Xu, Lin Chen, Wei Zhang. Neoadjuvant treatment strategies for hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2021; 13(12): 1550-1566 doi: 10.4240/wjgs.v13.i12.1550
|
14 |
Sanchari Bhattacharya, Laboni Mondal, Biswajit Mukherjee, Lopamudra Dutta, Iman Ehsan, Mita C. Debnath, Raghuvir H. Gaonkar, Murari M. Pal, Subrata Majumdar. Apigenin loaded nanoparticle delayed development of hepatocellular carcinoma in rats. Nanomedicine: Nanotechnology, Biology and Medicine 2018; 14(6): 1905 doi: 10.1016/j.nano.2018.05.011
|
15 |
. Experimental and Clinical Transplantation 2018; doi: 10.6002/ect.2018.0017
|
16 |
Zhan-Qi Wei, Yue-Wei Zhang. Transcatheter arterial chemoembolization followed by surgical resection for hepatocellular carcinoma: a focus on its controversies and screening of patients most likely to benefit. Chinese Medical Journal 2021; 134(19): 2275 doi: 10.1097/CM9.0000000000001767
|